Most healthcare mergers and acquisitions (M&A) professionals see a positive outlook for healthcare and life sciences deals next year, even as political uncertainty will be the biggest factor to upend transactions, according to a recent Merrill Insight poll of global M&A professionals.According to the poll, which included more than 200 respondents from the Americas and Europe, the Middle East and Africa (EMEA), 52% of respondents believe that the M&A market is headed in a positive
Read More
M&A
Pfizer, McKesson, Others Join MediLedger’s Blockchain Project Working Group
Leading life sciences and healthcare companies Pfizer Inc., McKesson Corporation, AmerisourceBergen Corporation, and Premier Inc. have joined the MediLedger Project Contracting and Chargebacks working group, a second working group running in parallel to the ongoing DSCSA working group started in 2017. MediLedger is an initiative of Chronicled, Inc., a San Francisco-based technology company, that builds blockchain-powered ecosystems and supply chain solutions.Network VisionMediLedger uses
Read More
KLAS: Allscripts Continues Trend of Sunrise & Paragon Losses in 2018
In terms of EMR purchasing, 2018 was the busiest of the past three years. This energy impacted every market sector, with the US government finalizing contracts, three large health systems changing EMRs, and the small-hospital market continuing to see churn, according to a new KLAS Report.The KLAS annual report, “US Hospital EMR Market Share 2019,” is based on acute care EMR purchasing activity (i.e., executed contracts) that occurred in the United States from January 1–December 31, 2018. KLAS
Read More
7 Trends Accelerating “TechBio” – The Life Sciences and Computer Sciences Convergence
We are now living in what I’m calling the
TechBio revolution. That’s not a typo that should read BioTech, but rather a
new way of looking at the convergence of technology and biology.
TechBio is defined as an engineering-first approach of biological processes for industrial, and other purposes, especially the genetic manipulation of microorganisms for the production of antibiotics, hormones, and so on. A process that uses AI and data-enabled discovery to complement the exploration of
Read More
Wolters Kluwer Harnesses AI to Bridge Data in EHRs to Speed Accuracy of HAIs
With healthcare M&A at an all-time high, many hospitals and health systems are feeling interoperability pains following mergers. Wolters Kluwer is now harnessing AI to bridge data in electronic health records (EHRs) and disparate systems, such as lab results, to improve how organizations identify and report hospital-acquired infections.Real World Data Integration Challenges for ProvidersIntegrating data from disparate EHRs across health systems continues to be a largely manual process. But
Read More
Why 2018 May Have Been A High-Water Mark for Digital Health Funding
Notwithstanding the quite significant stock market turmoil for publicly traded healthcare companies in recent months, the level of private investment activity continued to be quite strong this past quarter. According to Rock Health, 1Q19 registered just under $1.0 billion of investments made in 61 healthcare technology companies, which while below the trailing two year quarterly average of $1.4 billion, still suggests an annual investment pace running toward $4.0 billion. StartUp Health, which
Read More
PE Firm Considering Options Including Sale of RCM Provider Waystar
Private multi-asset alternative investment firm Bain Capital is reportedly considering options including the potential sale of revenue cycle management (RCM) company Waystar, Bloomberg reports. In 2018, Bain rebranded RCM companies Navicure and ZirMed as Waystar after merging the two companies together in 2017. Waystar Sale Could Value Company At More Than $3BBain has started early-stage discussions about a potential sale that could value the business at more than $3 billion, according to
Read More
Mercom: Global Digital Health/Health IT VC Funding Tops $2B in Q1 2019
Global venture capital (VC) funding in digital health/health IT, including private equity and corporate venture capital, reach $2 billion in funding in Q1 2019, according to market research firm Mercom Capital. The Q1 2019 Digital Health (Healthcare IT) Funding and M&A Report reveals $2B in funding across 149 deals compared to $1.4B across 142 deals in Q4 2018. VC funding in Q1 2019 was down 19% compared to the same quarter of last year (Q1 2018) when nearly $2.5 billion was raised in 187
Read More
March 2019 News, Merger & Acquisition, IPO, Public Company Performance Summary
A brief summary of noteworthy news, health IT M&A activity, IPOs, and public company performance during the month of March.
Noteworthy News
Amazon, JP Morgan, Berkshire Names New Joint Venture Haven
Amazon, J.P. Morgan, and Berkshire Hathaway name joint venture Haven. In January 2018, the three founding companies announced plans to create this independent organization, now called Haven, which is free from profit-making incentives and constraints. Haven’s focus is the 1.2 million
Read More
HealthQuest Capital Closes $440M Fund to Invest in Innovative Growth-Stage Companies
HealthQuest Capital, a Silicon Valley-based growth capital firm has closed a $440 million fund to invest growth-stage companies delivering innovation across all sectors of the healthcare industry to improve patient outcomes, enhance efficiency and reduce costs. Fund III was oversubscribed and closed at a hard cap. Target markets for Fund III include growth- and commercial-stage companies focusing on medical technologies, diagnostics, digital health, and innovative services.HealthQuest Capital
Read More
